Active substanceAmbroxolAmbroxol
Similar drugsTo uncover
  • Ambroben
    solution d / inhal. inwards 
  • Ambroben
    syrup inwards 
  • Ambroben
    pills inwards 
  • Ambroben
    solution in / in 
  • Ambroben
    capsules inwards 
  • Ambroghexal®
    syrup inwards 
    Sandoz d.     Slovenia
  • Ambroghexal®
    solution d / inhal. inwards 
    Sandoz d.     Slovenia
  • Ambroghexal®
    pills inwards 
    Sandoz d.     Slovenia
  • AmbroHEXAL®
    capsules inwards 
    HEXAL AG     Germany
  • Ambroxol
    syrup inwards 
    ECOLAB, CJSC     Russia
  • Ambroxol
    solution d / inhal. inwards 
    ATOLL, LLC     Russia
  • Ambroxol
    pills inwards 
  • Ambroxol
    syrup inwards 
  • Ambroxol
    syrup inwards 
  • Ambroxol
    syrup inwards 
    ATOLL, LLC     Russia
  • Ambroxol
    pills inwards 
  • Ambroxol
    pills inwards 
    VERTEKS, AO     Russia
  • Ambroxol
    pills inwards 
    OZONE, LLC     Russia
  • Ambroxol
    pills inwards 
  • Ambroxol
    syrup inwards 
    ROSLEKS PHARM, LLC     Russia
  • Ambroxol
    pills inwards 
  • Ambroxol
    pills inwards 
    LEKHIM-KHARKOV, CJSC     Ukraine
  • Ambroxol
    pills inwards 
    NIZHFARM, JSC     Russia
  • Ambroxol
    syrup inwards 
    FARMTECHNOLOGIYA, LLC     Republic of Belarus
  • Ambroxol
    pills inwards 
    ALSI Pharma, ZAO     Russia
  • Ambroxol
    solution d / inhal. inwards 
    UPDATE OF PFC, CJSC     Russia
  • Ambroxol
    pills inwards 
    UPDATE OF PFC, CJSC     Russia
  • Ambroxol
    syrup inwards 
    VERTEKS, AO     Russia
  • Ambroxol
    pills inwards 
    AVEKSIMA, JSC     Russia
  • Ambroxol
    solution inwards 
  • Ambroxol
    syrup inwards 
    VERTEKS, AO     Russia
  • Ambroxol Vramed
    syrup inwards 
    Sopharma, AO     Bulgaria
  • Ambroxol retard
    capsules inwards 
  • Ambroxol-Vial
    syrup inwards 
    VIAL, LLC     Russia
  • Ambroxol-3T
    syrup inwards 
  • Ambroxol Richter
    syrup inwards 
  • Ambroxol Richter
    pills inwards 
  • Ambroxol-SOLOfarm
    solution d / inhal. inwards 
    GROTEKS, LLC     Russia
  • Ambroxol-Hemofarm
    syrup inwards 
    Hemofarm AD     Serbia
  • Ambroxol-Hemofarm
    pills inwards 
    Hemofarm AD     Serbia
  • Ambrolore
    syrup inwards 
  • Ambrosan®
    solution inwards 
    PRO.MED.CS Prague as.     Czech Republic
  • Ambrosan®
    pills inwards 
    PRO.MED.CS Prague as.     Czech Republic
  • Bronhoxol
    pills inwards 
  • Bronhoxil®
    solution inwards 
  • Bronchorus®
    syrup inwards 
    SYNTHESIS, OJSC     Russia
  • Bronchorus®
    pills inwards 
    SYNTHESIS, OJSC     Russia
  • Wicks Active AmbroMed
    syrup inwards 
  • Lazolvan®
    lozenges inwards 
  • Lazolvan®
    solution d / inhal. inwards 
  • Lazolvan®
    syrup inwards 
  • Lazolvan®
    pills inwards 
  • Lazolvan® Max
    capsules inwards 
  • Lazognin®
    pills inwards 
  • Medox®
    syrup inwards 
    Zentiva c.s.     Czech Republic
  • Medox®
    pills inwards 
    Zentiva as.     The Slovak Republic
  • Neo-Bronchol®
    pills locally inwards 
    Divafarma GmbH     Germany
  • ORVIS® Bronho
    solution d / inhal. inwards 
    EVALAR, CJSC     Russia
  • Remebroks
    syrup inwards 
    REMEDIYA, LLC     Russia
  • Suprima-kof
    pills inwards 
  • Thoraxol Solidshn Tablets
    pills inwards 
    ATOLL, LLC     Russia
  • Flavamed®
    pills inwards 
  • Flavamed®
    solution inwards 
  • Flavamed® max
    pills inwards 
    Berlin-Chemie, AG     Germany
  • Halixol®
    pills inwards 
  • Halixol®
    syrup inwards 
  • Dosage form: & nbsppills
    Composition:

    Composition per one tablet:

    Active substance: Ambroxol hydrochloride - 30 mg.

    Auxiliary substances: corn starch, lactose (milk sugar), magnesium stearate, talc.

    Description:Round tablets of white color, flat-cylindrical shape with a bevel.
    Pharmacotherapeutic group:Expectorant, mucolytic agent
    ATX: & nbsp

    R.05.C.B.06   Ambroxol

    Pharmacodynamics:

    Mucolytic and expectorant.

    Has a secreto-motor, secretolitic and expectorant action.

    Ambroxol stimulates the motor activity of the cilia of the ciliated epithelium of the bronchial mucosa (mukinetic or secretory-motor action).

    Peristaltic contractions in the spiral of ciliary cells of the bronchial epithelium excrete mucus from the bronchial tree (mucociliary transport or mucociliary clearance). Ambroxol significantly improves mucociliary transport. Ambroxol stimulates serous cells of the glands of the bronchial mucosa, increases the content of mucous component of sputum and normalizes the disturbed ratio of serous and mucous components of sputum. By activating hydrolysing enzymes and enhancing the release of lysosomes from Clara cells, reduces the viscosity of the sputum and its adhesive properties (mucolytic or secretolytic action).

    Ambroxol increases the synthesis and secretion of surfactant (surfactant) in the alveoli and bronchi.

    As a result of these mechanisms, the viscosity of sputum is significantly reduced and its expectoration is improved.

    After ingestion, the effect comes in 30 minutes and lasts for 6-12 hours.
    Pharmacokinetics:

    Absorption is high (for any route of administration), the time to reach the maximum concentration is 2 hours, the connection with plasma proteins is 80%. Penetrates through the blood-brain barrier, placental barrier, excreted in breast milk. Metabolism - in the liver, forms dibromantranilic acid and glucuronic conjugates. The half-life is 7-12 hours. It is excreted by the kidneys: 90% in the form of water-soluble metabolites, in unchanged form - 5%.

    The half-life period increases with severe chronic renal failure, does not change if the liver function is impaired.

    Indications:

    Acute and chronic diseases of the respiratory tract, accompanied by the release of viscous sputum:

    - acute and chronic bronchitis;

    - pneumonia;

    - chronic obstructive pulmonary disease;

    - bronchial asthma with difficulty in sputum discharge;

    - bronchiectatic disease.

    Contraindications:

    Hypersensitivity, pregnancy (I trimester), age to 12 years (children under 12 years are prescribed Bronchorus in the form of syrup).

    In case of lactose intolerance (in case of glucose / galactose absorption disorder or sucrose / isomaltose insufficiency), it should be taken into account that lactose is included in the preparation.

    Carefully:

    Hepatic failure, renal insufficiency, peptic ulcer of stomach and duodenum, pregnancy (II-III trimester), the period of lactation.

    Dosing and Administration:

    Inside, after eating, squeezed a lot of liquid.

    Adults and children over 12 years of age - 1 tablet (30 mg) 3 times a day.

    If necessary, to enhance the therapeutic effect, you can appoint 2 tablets (60 mg) 2 times a day.

    In severe cases, the dose is not reduced throughout the course of treatment.

    Children under 12 years of age Bronchorus are prescribed in the form of syrup.

    It is not recommended to take the drug for more than 5 days without consulting a doctor.

    Side effects:

    Allergic reactions: skin rash, hives, angioedema, in some cases - allergic contact dermatitis, anaphylactic shock.

    Rarely - general weakness, headache, diarrhea, dysuria, exanthema, rhinorrhea, constipation.

    With prolonged use in high doses - gastralgia, nausea, vomiting.
    Overdose:

    Symptoms: nausea, vomiting, diarrhea, indigestion.

    Treatment: artificial vomiting, gastric lavage in the first 1-2 hours after taking the drug; reception of fat-containing products.

    Interaction:

    Joint use with antitussive drugs leads to difficulty in getting away from sputum while reducing the cough.

    Increases penetration into the bronchial secretion of amoxicillin, cefuroxime, erythromycin and doxycycline.

    Special instructions:

    Do not combine with antitussive drugs that make it difficult to withdraw phlegm.

    Form release / dosage:Tablets 30 mg.
    Packaging:

    10 tablets per contour cell pack.

    2, 3, 5, 10 contour mesh packages together with instructions for use are placed in a pack of cardboard.

    Storage conditions:
    In the dark place at a temperature of no higher than 25 C.
    Keep out of the reach of children.
    Shelf life:
    5 years.
    Do not use after the expiry date printed on the package.
    Terms of leave from pharmacies:Without recipe
    Registration number:LSR-005613/09
    Date of registration:13.07.2009
    Expiration Date:Unlimited
    The owner of the registration certificate:SYNTHESIS, OJSC SYNTHESIS, OJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp07.03.2017
    Illustrated instructions
      Instructions
      Up